Latest News and Press Releases
Want to stay updated on the latest news?
-
New York, April 09, 2021 (GLOBE NEWSWIRE) -- Alternus Energy Group PLC (NOTC:ALT) on pace to see a tenfold increase in its power capacity by the end of 2023 click herePredictiv AI Inc (CVE: PAI)...
-
Sydney, April 09, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies: Australian...
-
New York , April 08, 2021 (GLOBE NEWSWIRE) -- First Cobalt Corp (CVE:FCC) (OTCQX:FTSSF) (FRA:18P) hires commodities industry executive to market its refined cobalt production to EV and battery...
-
Sydney, April 08, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies: Twenty Seven Co...
-
New York, April 07, 2021 (GLOBE NEWSWIRE) -- BioHarvest Sciences Inc (CSE:BHSC) (OTCMKTS:CNVCF) (FRA:8MV) delivers record 1Q sales for its flagship functional food product VINIA in...
-
Sydney, April 07, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies: Alta Zinc Ltd...
-
New York , April 06, 2021 (GLOBE NEWSWIRE) -- EVmo Inc (OTCMKTS:YAYO) hits record yearly revenue in 2020 results; plans to make 2021 the year of the electric vehicle click here The Parent...
-
New York, April 01, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc (CVE:LXG) (OTCMKTS:LXXGF) ramps up manufacturing of its flagship MiQLab system click here GR Silver Mining Ltd (CVE:GRSL)...
-
Proactive news headlines including Creso Pharma, Danakali, Golden Rim Resources and Brookside Energy
Sydney, April 01, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies: Creso Pharma...
-
New York, March 31, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc (NYSEAMERICAN:AIM) headed in 2021 with $54.4M in capital as it advances Ampligen to treat COVID-19 and cancer click...